|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Cash held in Trust Account | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Prepaid income taxes | |||||||||||||||||||
| Cash and marketable securities held in Trust Account | |||||||||||||||||||
| Prepaid franchise tax | |||||||||||||||||||
| Digital assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Deferred offering costs | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Right-of-use asset | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Excise tax payable | |||||||||||||||||||
| Common stock to be redeemed | |||||||||||||||||||
| Income tax payable | |||||||||||||||||||
| Convertible promissory note – related party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total convertible promissory note – related party | |||||||||||||||||||
| Securities purchase agreement | |||||||||||||||||||
| Due to redeeming stockholders | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Advance from Profusa | |||||||||||||||||||
| Due to related party | |||||||||||||||||||
| Convertible senior notes and loans payable at fair value | |||||||||||||||||||
| Promissory notes and other | |||||||||||||||||||
| Convertible and promissory notes payable to related parties | |||||||||||||||||||
| PPP loan | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Warrant liabilities | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total warrant liabilities | |||||||||||||||||||
| Deferred tax liability | |||||||||||||||||||
| Warrant liabilities at fair value | |||||||||||||||||||
| Convertible loans payable at fair value | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Convertible preferred stock | |||||||||||||||||||
| Series A convertible preferred stock | |||||||||||||||||||
| Series B convertible preferred stock | |||||||||||||||||||
| Series C/C-1 convertible preferred stock | |||||||||||||||||||
| Total convertible preferred stock | |||||||||||||||||||
| Total convertible preferred stock | |||||||||||||||||||
| Stockholders’ Deficit: | |||||||||||||||||||
| Common stock: $0.0001 par value – 600,000,000 authorized shares at June 30, 2026 and December 31, 2025; 132,329 and 12,320 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ deficit | |||||||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||||||
Loading...
